In this week's News Desk, INSIDER presents industry reaction to FDA's kratom import alert and current legislation targeting the ingredient.

March 28, 2014

In February, FDA issued an import alert for kratom that effectively cut U.S. supply to the botanical. According to DEA, the new dietary ingredient has no legitimate medical use, and can lead to addiction and psychotic symptoms. FDA's import alert affected 27 companies, and another has pulled kratom from shelves in a voluntary recall.

In this week's News Desk, INSIDER presents industry reaction to the import alert and current legislation targeting the ingredient and its components.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like